Protocol review and monitoring within the Abramson Cancer Center (ACC) is undertaken by the Clinical Trials Scientific Review and Monitoring Committee (CTSRMC), Co-Chaired by Sunita Nasta, MD and John Plastaras, MD, PhD. The ACC continuously evaluates the structure, operations, quality, and conduct of its Protocol Review and Monitoring System. CTSRMC membership is evaluated yearly to ensure well-rounded and appropriate expertise in all aspects of cancer clinical research, which enables the Committee to conduct thorough and meaningful peer-review of proposed research protocols. In addition to scientific peer-review, the Committee undertakes evaluation of study feasibility and prioritization by each disease program as well as post-approval accrual and scientific progress. This promotes collaboration within the clinical programs and prevents duplication of effort, eliminates underperforming protocols, and facilitates effective resource utilization. By providing critical scientific review of protocols, the CTSRMC also supports the ACC's commitment to conducting innovative, scientifically progressive research. The Committee is supported by experienced senior administrative staff dedicated to operational quality and efficiency, allowing protocols to be reviewed and monitored in a timely fashion. The CTSRMC has implemented a customized web-based Clinical Trials Management System for tracking all cancer-related research conducted at the University of Pennsylvania. This system is used by all research teams to register protocols and subjects as well as to manage their day-to-day study support and data collection needs. The Clinical Trials Management System ties research teams together: improving information sharing, data quality, and subject safety. Through rigorous scientific review of merit, priority, and progress of cancer-related research, the CTSRMC has established itself as an integral, valued, and respected peer review body.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
United States
Zip Code
Shroff, Rachna T; Hendifar, Andrew; McWilliams, Robert R et al. (2018) Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation. JCO Precis Oncol 2018:
Fraietta, Joseph A; Lacey, Simon F; Orlando, Elena J et al. (2018) Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat Med 24:563-571
Anton, Lauren; Sierra, Luz-Jeannette; DeVine, Ann et al. (2018) Common Cervicovaginal Microbial Supernatants Alter Cervical Epithelial Function: Mechanisms by Which Lactobacillus crispatus Contributes to Cervical Health. Front Microbiol 9:2181
Williams, Austin D; Reyes, Sylvia A; Arlow, Renee L et al. (2018) Is Age Trumping Genetic Profiling in Clinical Practice? Relationship of Chemotherapy Recommendation and Oncotype DX Recurrence Score in Patients Aged Ann Surg Oncol 25:2875-2883
Krump, Nathan A; Liu, Wei; You, Jianxin (2018) Mechanisms of persistence by small DNA tumor viruses. Curr Opin Virol 32:71-79
Bengsch, Bertram; Ohtani, Takuya; Khan, Omar et al. (2018) Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells. Immunity 48:1029-1045.e5
Nair, Praful R; Alvey, Cory; Jin, Xiaoling et al. (2018) Filomicelles Deliver a Chemo-Differentiation Combination of Paclitaxel and Retinoic Acid That Durably Represses Carcinomas in Liver to Prolong Survival. Bioconjug Chem 29:914-927
Bhagwat, Neha; Dulmage, Keely; Pletcher Jr, Charles H et al. (2018) An integrated flow cytometry-based platform for isolation and molecular characterization of circulating tumor single cells and clusters. Sci Rep 8:5035
Raposo-Ferreira, Talita M M; Brisson, Becky K; Durham, Amy C et al. (2018) Characteristics of the Epithelial-Mesenchymal Transition in Primary and Paired Metastatic Canine Mammary Carcinomas. Vet Pathol 55:622-633
Kasner, Margaret T; Mick, Rosemarie; Jeschke, Grace R et al. (2018) Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibition. Invest New Drugs 36:657-666

Showing the most recent 10 out of 1047 publications